Provided by Tiger Trade Technology Pte. Ltd.

Agree

74.58
+0.70000.95%
Post-market: 74.05-0.5300-0.71%18:01 EDT
Volume:897.89K
Turnover:66.85M
Market Cap:9.28B
PE:40.28
High:74.84
Open:74.13
Low:74.05
Close:73.88
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:0.35
T/O Rate:0.73%
Dividend:3.14
Dividend Rate:4.21%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.46
PE(LYR):42.14

Loading ...

Yomiuri: Japan, U.K. Set to Agree on Next-Generation Reactor Development

Dow Jones
·
Jun 12

Govt, DPR Agree to Raise 2027 State Revenue Target

Tempo
·
Jun 12

JUNSHI BIO Shares Surge Over 5% Following Strategic Investment in Shanghai Biopharma Firm for ADC and Multispecific Antibody Development

Stock News
·
Jun 12

CStone Launches Global Phase I Trial for New EGFR/HER3 Bispecific ADC

TIPRANKS
·
Jun 12

CStone Pharma-B Launches Global Phase I Trial for Key ADC Candidate CS5007

Stock News
·
Jun 12

Immunome Achieves First Patient Dosing in Phase 1 Trial for IM-1617 ADC Candidate

Deep News
·
Jun 11

Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile

TIPRANKS
·
Jun 11

Euro Would Likely Recover Slowly if U.S., Iran Agree to a Deal -- Market Talk

Dow Jones
·
Jun 11

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress

GlobeNewswire
·
Jun 11

Agree Realty sets monthly distribution at R$ 0.12 per unit, payable July 21

Reuters
·
Jun 11

Is Agree Realty’s 4.3% Dividend Hike Quietly Reframing Its Income Story For ADC Investors?

Simply Wall St.
·
Jun 09

Agree Realty declares monthly dividend of $0.267 per share

Reuters
·
Jun 09

Agree Realty Declares Monthly Common and Preferred Dividends

THOMSON REUTERS
·
Jun 09

ADC Therapeutics Shares Fall After HC Wainwright Downgrade

MT Newswires Live
·
Jun 09

Agree Realty Executive Chairman Richard Agree reports purchase of 5,000 shares valued at $357,050

Reuters
·
Jun 08

ADC Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Jun 08

ADC Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
Jun 08

ADC Therapeutics Tumbles On Phase 3 Trial Safety Concerns, Joins Other Big Stocks Moving Lower In Thursday's Pre-Market Session (CORRECTED)

Benzinga_recent_news
·
Jun 07

Why Is ADC Therapeutics Stock Falling On Friday?

Benzinga
·
Jun 06

Junshi BIO to Contribute Patent Equipment Valued at RMB 53.08 Million for Stake in Shanghai Zhiyu Biopharma, Expanding into ADC and Multi-Specific Antibody R&D

Stock News
·
Jun 05